Population dynamics and relocation success of the oribi antelope (Ourebia ourebi) in KwaZulu-Natal, South Africa.

M. Sc. University of KwaZulu-Natal, Pietermaritzburg 2015.In South Africa, oribi (Ourebia ourebi) antelope are listed as vulnerable. The lack of understanding of their population dynamics makes it difficult for oribi conservation. To address these gaps, I used the Oribi Working Groups’ long-term survey database to determine 1) the trends (increasing, decreasing, stable) in oribi populations across KwaZulu-Natal, 2) the spatial distribution of these trends across the province, and 3) the factors influencing these trends. The overall oribi population trend for KwaZulu-Natal was linked with the number of survey returns submitted. This highlights the importance of landowners submitting consistent returns, resulting in more accurate population estimates. The majority of oribi populations across the province had decreasing population trends. I found that initial population size and the amount of suitable habitat available significantly affected oribi population growth rates. These growth rates increased when the availability of suitable habitat increased. In addition, grazing regime influenced growth rates. However, the variance observed was high, signifying that there may be other factors that are also responsible for driving these growth rates. Dog hunting was non-significant, however, because it is illegal, it was difficult to accurately measure its effect on oribi populations and thus should not be dismissed as a potential threat. Relocating oribi has been used as a conservation tool over the past 16 years. However, the success of these relocations has been poorly documented. To address this, I determined 1) the success rate of previous oribi relocations in KwaZulu-Natal, 2) the factors driving the success/failure of the relocations, and 3) whether relocation is a successful tool for the conservation of oribi in South Africa. I found a relocation success rate of only 10% (N = 1). Moreover, I found that following basic relocation criteria (e.g. the removal of threats (such as predators) or long-term post-release monitoring) was important in assuring relocation success. In all instances where relocations failed, key criteria were not considered prior to the relocation. This was in contrast to the one successful relocation, where all the criteria were considered and followed. Similar to my first study, I found that oribi population size, the availability of suitable habitat, and stocking rates of other large herbivores influenced growth rates, and ultimately, relocation success. Moreover, I found a significant interaction between suitable habitat available and stocking rates and their influence on population growth rates. Ultimately, this study highlights key factors that must be considered in any conservation or management decisions for oribi. In addition, prior to a relocation, landowners need to follow the basic criteria for successful relocations

Evaluating oribi translocations for conservation : the importance of translocation guidelines

At a global scale, anthropogenically-mediated disturbances have resulted in the extirpation of species and declines in both population and range size. Furthermore, land transformation and habitat fragmentation have limited the ability of species to disperse naturally throughout their ranges. To compensate for both this defaunation and disruption of animal movement patterns, rewilding and restoration are becoming increasingly important approaches to conserve and promote biodiversity. Central to both of these concepts, as well as wildlife management and conservation in general, is the translocation of species.The National Research Foundation (90783), the Endangered Wildlife Trust, and a Gay Langmuir bursary from the University of KwaZulu-Natal.https://sawma.co.za/african-journal-of-wildlife-researcham2022Mammal Research InstituteZoology and Entomolog

Nano-carrier based drug delivery systems for sustained antimicrobial agent release from orthopaedic cementous material

Total joint replacement (TJR), such as hip and knee replacement, is a popular procedure worldwide. Prosthetic joint infections (PJI) after this procedure have been widely reported, where treatment of such infections is complex with high cost and prolonged hospital stay. In cemented arthroplasties, the use of antibiotic loaded bone cement (ALBC) is a standard practice for the prophylaxis and treatment of PJI. Recently, the development of bacterial resistance by pathogenic microorganisms against most commonly used antibiotics increased the interest in alternative approaches for antimicrobial delivery systems such as nanotechnology. This review summarizes the efforts made to improve the antimicrobial properties of PMMA bone cements using nanotechnology based antibiotic and non-antibiotic delivery systems to overcome drawbacks of ALBC in the prophylaxis and treatment of PJIs after hip and knee replacement

Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes

Splicing factor (SF) gene mutations are frequent in myelodysplastic syndromes (MDS), and agents that modulate RNA splicing are hypothesized to provide clinical benefit. JNJ-64619178, a protein arginine methyltransferase 5 (PRMT5) inhibitor, was evaluated in patients with lower-risk (LR) MDS in a multi-part, Phase 1, multicenter study. The objectives were to determine a tolerable dose and to characterize safety, pharmacokinetics, pharmacodynamics, and preliminary clinical activity. JNJ-64619178 was administered on a 14 days on/7 days off schedule or every day on a 21-day cycle to patients with International Prognostic Scoring System (IPSS) Low or Intermediate-1 risk MDS who were red blood cell transfusion-dependent. Twenty-four patients were enrolled; 15 (62.5 %) patients had low IPSS risk score, while 18 (75.0 %) had an SF3B1 mutation. Median duration of treatment was 3.45 months (range: 0.03–6.93). No dose limiting toxicities were observed. The 0.5 mg once daily dose was considered better tolerated and chosen for dose expansion. Twenty-three (95.8 %) patients experienced treatment-emergent adverse events (TEAE). The most common TEAEs were neutropenia (15 [62.5 %]) and thrombocytopenia (14 [58.3 %]). JNJ-64619178 pharmacokinetics was dose-dependent. Target engagement as measured by plasma symmetric di-methylarginine was observed across all dose levels; however, variant allele frequency of clonal mutations in bone marrow or blood did not show sustained reductions from baseline. No patient achieved objective response or hematologic improvement per International Working Group 2006 criteria, or transfusion independence. A tolerable dose of JNJ-64619178 was identified in patients with LR MDS. However, no evidence of clinical benefit was observed.This study was supported by Janssen Research & Development, LLC.Peer reviewe

PANC Study (Pancreatitis: A National Cohort Study): national cohort study examining the first 30 days from presentation of acute pancreatitis in the UK

Abstract Background Acute pancreatitis is a common, yet complex, emergency surgical presentation. Multiple guidelines exist and management can vary significantly. The aim of this first UK, multicentre, prospective cohort study was to assess the variation in management of acute pancreatitis to guide resource planning and optimize treatment. Methods All patients aged greater than or equal to 18 years presenting with acute pancreatitis, as per the Atlanta criteria, from March to April 2021 were eligible for inclusion and followed up for 30 days. Anonymized data were uploaded to a secure electronic database in line with local governance approvals. Results A total of 113 hospitals contributed data on 2580 patients, with an equal sex distribution and a mean age of 57 years. The aetiology was gallstones in 50.6 per cent, with idiopathic the next most common (22.4 per cent). In addition to the 7.6 per cent with a diagnosis of chronic pancreatitis, 20.1 per cent of patients had a previous episode of acute pancreatitis. One in 20 patients were classed as having severe pancreatitis, as per the Atlanta criteria. The overall mortality rate was 2.3 per cent at 30 days, but rose to one in three in the severe group. Predictors of death included male sex, increased age, and frailty; previous acute pancreatitis and gallstones as aetiologies were protective. Smoking status and body mass index did not affect death. Conclusion Most patients presenting with acute pancreatitis have a mild, self-limiting disease. Rates of patients with idiopathic pancreatitis are high. Recurrent attacks of pancreatitis are common, but are likely to have reduced risk of death on subsequent admissions. </jats:sec

Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

Summary Background Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income countries globally, and identified factors associated with mortality. Methods We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation, and Hirschsprung’s disease. Recruitment was of consecutive patients for a minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. We did a complete case analysis. Findings We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal malformation, and 517 with Hirschsprung’s disease) from 264 hospitals (89 in high-income countries, 166 in middleincome countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male. Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3). Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups). Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in lowincome countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries; p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11], p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20 [1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention (ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed (ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65 [0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality. Interpretation Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between lowincome, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger than 5 years by 2030

Correlation of the Condylar Guidance Obtained by Protrusive Interocclusal Record and Panoramic Radiographs in Completely Edentulous Patients: An in Vivo Study

Aim: The purpose of this study was to evaluate the reliability of programming the articulator using the radiographs and the interocclusal records made during Jaw relation (Arrow point tracing). Materials and Method: The study comprised of 15 edentulous subjects with well formed maxillary and mandibular ridges, with no signs and symptoms of temporomandibular joint disorders and neuromuscular disorders. Digital Orthopantomograph was taken for all the subjects. The condylar guidance angles were traced on Orthopantomograph for right and left sides and the values were recorded. The protrusive interocclusal records were made at jaw relation stage and at try-in stage using bite registration paste for all subjects. These interocclusal records were used to programme the Semi-adjustable articulator (Hanau Wide Vue) and the condylar guidance values on the right and left sides were recorded. The condylar guidance values so obtained were compared with the values obtained by Orthopantomograph. The condylar guidance values obtained by the various procedures were subjected to independent t-test and Pearson correlation test. Results: The results showed statistically significant difference between the condylar guidance values obtained from Orthopantomograph (Radiograph) and the condylar guidance values obtained at the stage of jaw relation. Conclusion: Within the limitations of the study, it can be concluded that the condylar guidance values obtained from the Radiographs were higher than those obtained at the stage of jaw relation recording stage

Assessing the performance of oribi antelope populations at multiple scales : the limitations of citizen-led oribi conservation

Effective monitoring programmes are critical to understand and mitigate declining wildlife populations. In South Africa, the majority of oribi antelope (Ourebia ourebi ourebi) occur on private rangelands as broadly distributed and highly-fragmented populations. Thus, to effectively manage such a species, conservation organizations rely on citizen science-led conservation initiatives, whereby members of the public provide data on oribi population demographics and potential threats. Using these data, we estimated the total oribi population size and assessed the population trend of oribi in KwaZulu-Natal, South Africa, over a 14-year period (2001–2014).We found that the oribi population has declined by 30% over the 14 years. However, oribi population estimates were highly correlated with the number of returned survey forms. This relationship makes it difficult to accurately assess population trends and almost impossible to determine if any changes in conservation management have influenced oribi populations. Thus, issues associated with citizen science and data quality (i.e. participation levels),may limit the ability of the oribi census to accurately inform oribi conservation and management. We discuss the value and limitations of citizen science in oribi conservation with the ultimate goal of improving citizen-led oribi conservation.The National Research Foundation (90783), the Endangered Wildlife Trust, and a Gay Langmuir bursary from the University of KwaZulu-Natal.https://sawma.co.za/african-journal-of-wildlife-researcham2022Mammal Research InstituteZoology and Entomolog